Atlas Trials

Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC

Clinical trial NCT00859339 · TERMINATED

Trial details

NCT number
NCT00859339
Sponsor
Noah Hahn, M.D.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Transitional Cell Carcinoma of the Bladder
Start date
2009-03-01
Primary completion
2011-04-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.